🔗 Share this article

A shadow economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and detailed instructions for preparing or injecting at home.

After moments of joining one community, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Details and Costs

Within these groups, posts display dark colored parcels with postal service labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.

Her team has already encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant health risks”.